| 
				The companies did not provide financial terms of the new 
				contract.
 On Tuesday, CVS said the companies had failed to agree on 
				pricing and that Walmart was leaving the pharmacy network for 
				the prescription drug plans that CVS manages for companies and 
				health insurers and for the Medicaid program for low income 
				people.
 
 The companies also said on Tuesday they were still in 
				discussions.
 
 CVS shares gained 1.6 percent to $64.76 in premarket trading, 
				recouping some of its Tuesday losses.
 
 "We view the agreement positively for CVS," Cantor Fitzgerald 
				analyst Steven Halper said in a research note, explaining that 
				the loss of Walmart pharmacies could have negatively impacted 
				CVS' ability to sign customers for its 2020 prescription drug 
				plans.
 
 In addition to its retail pharmacies and stores, CVS is one of 
				the country's biggest pharmacy benefit managers and, after 
				buying Aetna, one of its top health insurance companies. Its 
				prescription plans for the Medicare population were unaffected 
				by the contract dispute as was its Sam's Club agreements.
 
 Walmart senior vice president Sean Slovenski described the terms 
				as "fair and equitable" in a press release.
 
 (Reporting by Caroline Humer in New York and Ankur Banerjee in 
				Bengaluru; Editing by Shounak Dasgupta and Chizu Nomiyama)
 
			[© 2019 Thomson Reuters. All rights 
				reserved.] Copyright 2019 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed.  
				Thompson Reuters is solely responsible for this content. 
				 |  |